Home›Legal›NAD+ in Pennsylvania
NAD+ in Pennsylvania: Legal Status & Provider Guide (2026)
Quick Answer
NAD+ is a prescription substance in the United States. NAD+ in injectable form can be lawfully compounded by 503A pharmacies under a valid prescription. Oral NAD+ precursors (NR, NMN) are available as dietary supplements without a prescription. Injectable NAD+ protocols require physician oversight and pharmacy compounding. In Pennsylvania, compounding is governed by the Pennsylvania State Board of Pharmacy (PSBP). Pennsylvania certified registered nurse practitioners (CRNPs) may prescribe compounded medications including peptides within a collaborative agreement. Physician assistants also require supervision agreements. Pennsylvania has moderately permissive telehealth rules, allowing prescribing after an appropriate telehealth evaluation. Pennsylvania prescribers must hold an active Pennsylvania license to prescribe to Pennsylvania residents.
Federal Legal Status
FDA Approval Status
NAD+ is not FDA-approved as a prescription drug. It is generally recognized as a nutritional supplement precursor (via NR and NMN) when taken orally. Injectable NAD+ has been compounded by licensed pharmacies and is considered legally permissible under current FDA guidance in IV/injection form when prescribed.
Compounding Pharmacy Rules (Federal)
Injectable NAD+ (nicotinamide adenine dinucleotide) can be compounded by licensed 503A pharmacies under a valid prescription. It is not on the 503B bulk substances list but has historically been offered by many compounding pharmacies for IV infusion or subcutaneous injection under physician oversight. Its regulatory status is more permissive than most synthetic peptides.
Also Known As
Nicotinamide Adenine Dinucleotide · NAD · β-NAD+
Primary Research Areas
- Cellular energy
- Anti-aging
- Neurological support
- Addiction recovery support
- Metabolic health
Pennsylvania Pharmacy Board & Compounding Rules
Compounding Overview
Pennsylvania's State Board of Pharmacy regulates compounding pharmacies with detailed sterile and non-sterile compounding standards. Pennsylvania has historically been home to several large-scale compounding operations. The state enforces USP 797 standards for sterile products and requires annual inspections for high-risk compounding. Pennsylvania is part of the northeastern corridor with significant demand from New York, New Jersey, and Delaware markets.
Notable Rules
- Pennsylvania requires pharmacies engaged in sterile compounding to have a separate license category.
- Annual inspections are required for pharmacies performing high-risk sterile compounding.
- Pennsylvania shares regulatory burden with the FDA for pharmacies also registered as 503B outsourcing facilities.
- Non-resident pharmacies shipping compounds into Pennsylvania must be registered with the PSBP.
- Pennsylvania and New York maintain some reciprocal licensing arrangements for pharmacy professionals.
Prescribing Requirements in Pennsylvania
Pennsylvania certified registered nurse practitioners (CRNPs) may prescribe compounded medications including peptides within a collaborative agreement. Physician assistants also require supervision agreements. Pennsylvania has moderately permissive telehealth rules, allowing prescribing after an appropriate telehealth evaluation. Pennsylvania prescribers must hold an active Pennsylvania license to prescribe to Pennsylvania residents.
About NAD+
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in all living cells, central to energy metabolism and DNA repair. Research interest has expanded significantly with studies linking NAD+ decline to aging. Clinical research focuses on replenishment via IV infusion or oral precursors.
For more research information, mechanism of action, and provider availability, see the NAD+ research profile on PeptideBase.
Frequently Asked Questions
- Is injectable NAD+ legal?
- Injectable NAD+ can be legally compounded by licensed 503A compounding pharmacies under a valid physician prescription. It is not FDA-approved as a drug but has a permissive compounding status compared to many synthetic peptides.
- What is the difference between oral NAD+ supplements and IV NAD+?
- Oral supplements typically deliver NAD+ precursors (NR or NMN) which the body converts. IV NAD+ delivers the coenzyme directly into the bloodstream, which proponents claim produces faster and more pronounced effects, though comparative clinical data is limited.
NAD+ Providers in Pennsylvania
No providers currently listed in Pennsylvania for NAD+. Browse the full directory to find providers offering NAD+.
Browse all NAD+ providers →NAD+ Legal Status in Other States
Pharmacy board rules and compounding regulations vary by state. Compare NAD+ legal status across other major markets:
Content review: This educational overview is prepared by the PeptideBase editorial team and reviewed for factual accuracy. Reviewer byline coming soon (gated on 4.4). Last updated: .